Drawing for MELPIDAH

USPTO serial 99928840

MELPIDAH

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
LAMONT, MIAH ROSENBERG
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MELPIDAH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Caroline E. Bryce

Caroline E. Bryce Sheridan Ross P.C.1560 BroadwaySuite 1200Denver, CO 80202

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for gene therapy for the treatment of progressive genetic neurological disorders, neurogenetic diseases, neurodegenerative diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 7, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 7, 2026DOCKASSIGNED TO EXAMINER—
Jul 8, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 8, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 8, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance